Who invested in Edge Therapeutics?
Edge Therapeutics's investors include Venrock, Sofinnova Investments, New Leaf Venture Partners, Hercules Technology Growth Capital and BioMed Ventures, and 3 more on record.
United States · Series C startup
7 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$101Mraised across 7 rounds since 2010, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $56M sold, first sale Apr 2015
No investor was named in the report.
From a historical funding recordSEC filing: $7.9M sold, first sale Nov 2014
From a historical funding recordSEC filing: $7.9M sold, first sale Nov 2014
No investor was named in the report.
Reported by sec.govSEC filing: $119K sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $220K sold, first sale Apr 2011
No investor was named in the report.
From a historical funding recordSEC filing: $635K sold, first sale Aug 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Edge Therapeutics's investors include Venrock, Sofinnova Investments, New Leaf Venture Partners, Hercules Technology Growth Capital and BioMed Ventures, and 3 more on record.
Edge Therapeutics has raised $101M across 7 rounds since 2010.
Edge Therapeutics's most recent round was a Series C of $56M in Apr 2015.
Its most recent round, $56M in Apr 2015, is also its largest on record.
Edge Therapeutics's first round on record, in Jun 2013, was backed by Maxim Group.
Edge Therapeutics's latest named round is a Series C, in Apr 2015.
Edge Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.